Sepsis is a life-threatening response to infection that often leads to tissue damage, organ failure, and death.
Mortality significantly increases for every hour without the right antimicrobial.
dRAST can help guide targeted antimicrobial therapy while limiting inappropriate and antimicrobial resistance through fast AST results.

Optimize antimicrobial therapy earlier for patients with sepsis with Rapid AST results
in as low as 4 hours on positive blood culture vs. 2-3 days with conventional methods.

Products of QuantaMatrix are available in the European markets, the home of diagnostic testings.